Understanding quality of life and outcomes in anal cancer patients
ANCA II - Quality of Life and Functional Outcome in Patients With Anal Cancer
This study looks at how anal cancer affects patients' quality of life and health outcomes from diagnosis through treatment to see what challenges they face.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 600 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Sahlgrenska University Hospital Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Gothenburg) |
| Trial ID | NCT04792892 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on patients diagnosed with anal cancer to assess their quality of life and functional outcomes. It aims to track patients from the point of diagnosis, monitoring early treatment toxicity and long-term morbidity following chemotherapy and radiotherapy. By utilizing questionnaires, the study seeks to gather comprehensive data on the experiences and challenges faced by these patients throughout their treatment journey.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 years old who have been diagnosed with anal squamous carcinoma within the last two months.
Not a fit: Patients who are unable to provide informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the quality of life and long-term effects of treatment for anal cancer patients, potentially guiding future care strategies.
How similar studies have performed: While there have been studies on quality of life in cancer patients, this specific focus on anal cancer outcomes is relatively novel and underexplored.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \> 18 years * Anal squamous carcinoma diagnosed within the last 2 months Exclusion Criteria: -No informed consent
Where this trial is running
Gothenburg
- Dept. of Surgery, Sahlgrenska University Hospital/Ostra — Gothenburg, Sweden (Recruiting)
Study contacts
- Study coordinator: Eva Angenete
- Email: eva.angenete@vgregion.se
- Phone: 0760514441
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.